<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37175745</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8034</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24098034</ELocationID><Abstract><AbstractText>Patients who have recovered from coronavirus disease 2019 (COVID-19) infection may experience chronic fatigue when exercising, despite no obvious heart or lung abnormalities. The present lack of effective treatments makes managing long COVID a major challenge. One of the underlying mechanisms of long COVID may be mitochondrial dysfunction. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can alter the mitochondria responsible for energy production in cells. This alteration leads to mitochondrial dysfunction which, in turn, increases oxidative stress. Ultimately, this results in a loss of mitochondrial integrity and cell death. Moreover, viral proteins can bind to mitochondrial complexes, disrupting mitochondrial function and causing the immune cells to over-react. This over-reaction leads to inflammation and potentially long COVID symptoms. It is important to note that the roles of mitochondrial damage and inflammatory responses caused by SARS-CoV-2 in the development of long COVID are still being elucidated. Targeting mitochondrial function may provide promising new clinical approaches for long-COVID patients; however, further studies are needed to evaluate the safety and efficacy of such approaches.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tsung-Hsien</ForeName><Initials>TH</Initials><Identifier Source="ORCID">0000-0002-1542-1495</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 60002, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chia-Jung</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 60002, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Peir-Haur</ForeName><Initials>PH</Initials><Identifier Source="ORCID">0000-0002-5963-6981</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 60002, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life and Health Science, Chia-Nan University of Pharmacy and Science, Tainan 717301, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028361" MajorTopicYN="Y">Mitochondrial Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">electron transport chain</Keyword><Keyword MajorTopicYN="N">inflammatory responses</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mitochondrial disorder</Keyword><Keyword MajorTopicYN="N">oxidative phosphorylation</Keyword><Keyword MajorTopicYN="N">pathogen-associated molecular patterns (PAMPs)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37175745</ArticleId><ArticleId IdType="pmc">PMC10179190</ArticleId><ArticleId IdType="doi">10.3390/ijms24098034</ArticleId><ArticleId IdType="pii">ijms24098034</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xie Y., Wang Z., Liao H., Marley G., Wu D., Tang W. Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: Systematic review and meta-analysis. BMC Infect. Dis. 2020;20:640. doi: 10.1186/s12879-020-05371-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05371-2</ArticleId><ArticleId IdType="pmc">PMC7457225</ArticleId><ArticleId IdType="pubmed">32867706</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.H., Hsu M.T., Lee M.Y., Chou C.K. Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses. 2022;14:1188. doi: 10.3390/v14061188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061188</ArticleId><ArticleId IdType="pmc">PMC9228950</ArticleId><ArticleId IdType="pubmed">35746659</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kessel S.A.M., Olde Hartman T.C., Lucassen P., van Jaarsveld C.H.M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam. Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Human Services, Office of the Assistant Secretary for Health . National Research Action Plan on Long COVID. Volume 20201 U.S. Department of Health &amp; Human Services; Washington, DC, USA: 2022.</Citation></Reference><Reference><Citation>National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases  Long COVID or Post-COVID Conditions.  [(accessed on 16 December 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic Fatigue and Postexertional Malaise in People Living with Long COVID: An Observational Study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., Cullinan M., Lutchmansingh D.D., Gulati M., Possick J.D., Systrom D.M., Waxman A.B. Persistent Exertional Intolerance After COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwendinger F., Knaier R., Radtke T., Schmidt-Trucksass A. Low Cardiorespiratory Fitness Post-COVID-19: A Narrative Review. Sports Med. 2023;53:51&#x2013;74. doi: 10.1007/s40279-022-01751-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-022-01751-7</ArticleId><ArticleId IdType="pmc">PMC9483283</ArticleId><ArticleId IdType="pubmed">36115933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Voit-Bak K., Donate T., Rodionov R.N., Gainetdinov R.R., Tselmin S., Kanczkowski W., Muller G.M., Achleitner M., Wang J., et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Mol. Psychiatry. 2022;27:34&#x2013;37. doi: 10.1038/s41380-021-01148-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01148-4</ArticleId><ArticleId IdType="pmc">PMC8209771</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabanella F., Barbato C., Corbi N., Fiore M., Petrella C., de Vincentiis M., Greco A., Ferraguti G., Corsi A., Ralli M., et al. Exploring Mitochondrial Localization of SARS-CoV-2 RNA by Padlock Assay: A Pilot Study in Human Placenta. Int. J. Mol. Sci. 2022;23:2100. doi: 10.3390/ijms23042100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042100</ArticleId><ArticleId IdType="pmc">PMC8875563</ArticleId><ArticleId IdType="pubmed">35216211</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman S., Netland J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol. 2009;7:439&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2830095</ArticleId><ArticleId IdType="pubmed">19430490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K.E., Fazal F.M., Parker K.R., Zou J., Chang H.Y. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus. Cell Syst. 2020;11:102&#x2013;108.e3. doi: 10.1016/j.cels.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7305881</ArticleId><ArticleId IdType="pubmed">32673562</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Zhou Z., Min W. Mitochondria, Oxidative Stress and Innate Immunity. Front. Physiol. 2018;9:1487. doi: 10.3389/fphys.2018.01487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01487</ArticleId><ArticleId IdType="pmc">PMC6200916</ArticleId><ArticleId IdType="pubmed">30405440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran K., Maity S., Muthukumar A.R., Kandala S., Tomar D., Abd El-Aziz T.M., Allen C., Sun Y., Venkatesan M., Madaris T.R., et al. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics. iScience. 2022;25:103722. doi: 10.1016/j.isci.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8720045</ArticleId><ArticleId IdType="pubmed">35005527</ArticleId></ArticleIdList></Reference><Reference><Citation>Dela Cruz C.S., Kang M.J. Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases. Mitochondrion. 2018;41:37&#x2013;44. doi: 10.1016/j.mito.2017.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.12.001</ArticleId><ArticleId IdType="pmc">PMC5988941</ArticleId><ArticleId IdType="pubmed">29221810</ArticleId></ArticleIdList></Reference><Reference><Citation>Grazioli S., Pugin J. Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases. Front. Immunol. 2018;9:832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5946030</ArticleId><ArticleId IdType="pubmed">29780380</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi S., Guilbaud E., Tait S.W.G., Yamazaki T., Galluzzi L. Mitochondrial control of inflammation. Nat. Rev. Immunol. 2023;23:159&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310369</ArticleId><ArticleId IdType="pubmed">35879417</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 2016;3:237&#x2013;261. doi: 10.1146/annurev-virology-110615-042301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Subissi L., Posthuma C.C., Collet A., Zevenhoven-Dobbe J.C., Gorbalenya A.E., Decroly E., Snijder E.J., Canard B., Imbert I. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc. Natl. Acad. Sci. USA. 2014;111:E3900&#x2013;E3909. doi: 10.1073/pnas.1323705111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1323705111</ArticleId><ArticleId IdType="pmc">PMC4169972</ArticleId><ArticleId IdType="pubmed">25197083</ArticleId></ArticleIdList></Reference><Reference><Citation>Brian D.A., Baric R.S. Coronavirus Replication and Reverse Genetics. Volume 287. Springer; Berlin/Heidelberg, Germany: 2005. Coronavirus genome structure and replication; pp. 1&#x2013;30. Current Topics in Microbiology and Immunology.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7120446</ArticleId><ArticleId IdType="pubmed">15609507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.J., Chen T.H. NSP16 2&#x2032;-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies. Viruses. 2021;13:538. doi: 10.3390/v13040538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040538</ArticleId><ArticleId IdType="pmc">PMC8063928</ArticleId><ArticleId IdType="pubmed">33804957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesheh M.M., Hosseini P., Soltani S., Zandi M. An overview on the seven pathogenic human coronaviruses. Rev. Med. Virol. 2022;32:e2282. doi: 10.1002/rmv.2282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2282</ArticleId><ArticleId IdType="pubmed">34339073</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrag M.A., Amer H.M., Bhat R., Hamed M.E., Aziz I.M., Mubarak A., Dawoud T.M., Almalki S.G., Alghofaili F., Alnemare A.K., et al. SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis. Int. J. Environ. Res. Public Health. 2021;18:6312. doi: 10.3390/ijerph18126312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18126312</ArticleId><ArticleId IdType="pmc">PMC8296125</ArticleId><ArticleId IdType="pubmed">34200934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen Y., Li Y., Huang F., Luo B., Yuan Y., Xia B., Ma X., Yang T., Yu F., et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Iota. Proc. Natl. Acad. Sci. USA. 2021;118:e2024202118. doi: 10.1073/pnas.2024202118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024202118</ArticleId><ArticleId IdType="pmc">PMC8201919</ArticleId><ArticleId IdType="pubmed">34021074</ArticleId></ArticleIdList></Reference><Reference><Citation>Azad G.K., Khan P.K. Variations in Orf3a protein of SARS-CoV-2 alter its structure and function. Biochem. Biophys. Rep. 2021;26:100933. doi: 10.1016/j.bbrep.2021.100933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2021.100933</ArticleId><ArticleId IdType="pmc">PMC7839395</ArticleId><ArticleId IdType="pubmed">33527091</ArticleId></ArticleIdList></Reference><Reference><Citation>Castano-Rodriguez C., Honrubia J.M., Gutierrez-Alvarez J., DeDiego M.L., Nieto-Torres J.L., Jimenez-Guardeno J.M., Regla-Nava J.A., Fernandez-Delgado R., Verdia-Baguena C., Queralt-Martin M., et al. Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis. mBio. 2018;9:e02325-17. doi: 10.1128/mBio.02325-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02325-17</ArticleId><ArticleId IdType="pmc">PMC5964350</ArticleId><ArticleId IdType="pubmed">29789363</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu K.L., Yuen K.S., Castano-Rodriguez C., Ye Z.W., Yeung M.L., Fung S.Y., Yuan S., Chan C.P., Yuen K.Y., Enjuanes L., et al. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019;33:8865&#x2013;8877. doi: 10.1096/fj.201802418R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802418R</ArticleId><ArticleId IdType="pmc">PMC6662968</ArticleId><ArticleId IdType="pubmed">31034780</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Y., Nabar N.R., Shi C.S., Kamenyeva O., Xiao X., Hwang I.Y., Wang M., Kehrl J.H. SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death. Cell Death Dis. 2018;9:904. doi: 10.1038/s41419-018-0917-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0917-y</ArticleId><ArticleId IdType="pmc">PMC6125346</ArticleId><ArticleId IdType="pubmed">30185776</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno Y., Kimura I., Uriu K., Fukushi M., Irie T., Koyanagi Y., Sauter D., Gifford R.J., Consortium U.-C., Nakagawa S., et al. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant. Cell Rep. 2020;32:108185. doi: 10.1016/j.celrep.2020.108185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108185</ArticleId><ArticleId IdType="pmc">PMC7473339</ArticleId><ArticleId IdType="pubmed">32941788</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel Y., Mizrahi O., Nachshon A., Weingarten-Gabbay S., Morgenstern D., Yahalom-Ronen Y., Tamir H., Achdout H., Stein D., Israeli O., et al. The coding capacity of SARS-CoV-2. Nature. 2021;589:125&#x2013;130. doi: 10.1038/s41586-020-2739-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2739-1</ArticleId><ArticleId IdType="pubmed">32906143</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O&#x2019;Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459&#x2013;468. doi: 10.1038/s41586-020-2286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachim A., Kavian N., Cohen C.A., Chin A.W.H., Chu D.K.W., Mok C.K.P., Tsang O.T.Y., Yeung Y.C., Perera R., Poon L.L.M., et al. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat. Immunol. 2020;21:1293&#x2013;1301. doi: 10.1038/s41590-020-0773-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0773-7</ArticleId><ArticleId IdType="pubmed">32807944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.G., Huang W., Lee H., van de Leemput J., Kane M.A., Han Z. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor. Cell Biosci. 2021;11:58. doi: 10.1186/s13578-021-00568-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00568-7</ArticleId><ArticleId IdType="pmc">PMC7993076</ArticleId><ArticleId IdType="pubmed">33766124</ArticleId></ArticleIdList></Reference><Reference><Citation>Miorin L., Kehrer T., Sanchez-Aparicio M.T., Zhang K., Cohen P., Patel R.S., Cupic A., Makio T., Mei M., Moreno E., et al. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc. Natl. Acad. Sci. USA. 2020;117:28344&#x2013;28354. doi: 10.1073/pnas.2016650117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016650117</ArticleId><ArticleId IdType="pmc">PMC7668094</ArticleId><ArticleId IdType="pubmed">33097660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecky-Bromberg S.A., Martinez-Sobrido L., Frieman M., Baric R.A., Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007;81:548&#x2013;557. doi: 10.1128/JVI.01782-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01782-06</ArticleId><ArticleId IdType="pmc">PMC1797484</ArticleId><ArticleId IdType="pubmed">17108024</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.Y., Liao C.H., Wang Q., Tan Y.J., Luo R., Qiu Y., Ge X.Y. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res. 2020;286:198074. doi: 10.1016/j.virusres.2020.198074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198074</ArticleId><ArticleId IdType="pmc">PMC7309931</ArticleId><ArticleId IdType="pubmed">32589897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato K., Ikliptikawati D.K., Kobayashi A., Kondo H., Lim K., Hazawa M., Wong R.W. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex. Biochem. Biophys. Res. Commun. 2021;536:59&#x2013;66. doi: 10.1016/j.bbrc.2020.11.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.11.115</ArticleId><ArticleId IdType="pmc">PMC7733692</ArticleId><ArticleId IdType="pubmed">33360543</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D., Rajsbaum R., Shi P.Y. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi: 10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Z., Xia H., Rajsbaum R., Xia X., Wang H., Shi P.Y. Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response. Cell. Mol. Immunol. 2021;18:746&#x2013;748. doi: 10.1038/s41423-020-00603-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00603-6</ArticleId><ArticleId IdType="pmc">PMC7815971</ArticleId><ArticleId IdType="pubmed">33473190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Huang C., Zhou Z., Huang Z., Su L., Kang S., Chen X., Chen Q., He S., Rong X., et al. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14(+) monocytes. iScience. 2021;24:102187. doi: 10.1016/j.isci.2021.102187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102187</ArticleId><ArticleId IdType="pmc">PMC7879101</ArticleId><ArticleId IdType="pubmed">33615195</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D.X., Fung T.S., Chong K.K., Shukla A., Hilgenfeld R. Accessory proteins of SARS-CoV and other coronaviruses. Antiviral Res. 2014;109:97&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7113789</ArticleId><ArticleId IdType="pubmed">24995382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.Y., Ping Y.H., Lee H.C., Chen K.H., Lee Y.M., Chan Y.J., Lien T.C., Jap T.S., Lin C.H., Kao L.S., et al. Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis. J. Infect. Dis. 2007;196:405&#x2013;415. doi: 10.1086/519166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/519166</ArticleId><ArticleId IdType="pmc">PMC7204190</ArticleId><ArticleId IdType="pubmed">17597455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong H.H., Fung T.S., Fang S., Huang M., Le M.T., Liu D.X. Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3. Virology. 2018;515:165&#x2013;175. doi: 10.1016/j.virol.2017.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.12.028</ArticleId><ArticleId IdType="pmc">PMC7112132</ArticleId><ArticleId IdType="pubmed">29294448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L., Ren L., et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 2020;11:3810. doi: 10.1038/s41467-020-17665-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X., Fu B., Yin S., Li Z., Liu H., Zhang H., Xing N., Wang Y., Xue W., Xiong Y., et al. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience. 2021;24:102293. doi: 10.1016/j.isci.2021.102293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102293</ArticleId><ArticleId IdType="pmc">PMC7942160</ArticleId><ArticleId IdType="pubmed">33723527</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C.S., Qi H.Y., Boularan C., Huang N.N., Abu-Asab M., Shelhamer J.H., Kehrl J.H. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J. Immunol. 2014;193:3080&#x2013;3089. doi: 10.4049/jimmunol.1303196.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303196</ArticleId><ArticleId IdType="pmc">PMC4179872</ArticleId><ArticleId IdType="pubmed">25135833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreimendahl S., Rassow J. The Mitochondrial Outer Membrane Protein Tom70-Mediator in Protein Traffic, Membrane Contact Sites and Innate Immunity. Int. J. Mol. Sci. 2020;21:7262. doi: 10.3390/ijms21197262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197262</ArticleId><ArticleId IdType="pmc">PMC7583919</ArticleId><ArticleId IdType="pubmed">33019591</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K.K., Chaubey G., Chen J.Y., Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell. Physiol. 2020;319:C258&#x2013;C267. doi: 10.1152/ajpcell.00224.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez Andres A., Feng Y., Campos A.R., Yin J., Yang C.C., James B., Murad R., Kim H., Deshpande A.J., Gordon D.E., et al. SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells. bioRxiv. 2020 doi: 10.1101/2020.08.18.256776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.18.256776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H., Jureka A.S., Obernier K., Guo J.Z., Batra J., et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370:eabe9403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808408</ArticleId><ArticleId IdType="pubmed">33060197</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H.W., Zhang H.N., Meng Q.F., Xie J., Li Y., Chen H., Zheng Y.X., Wang X.N., Qi H., Zhang J., et al. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. Cell. Mol. Immunol. 2020;17:998&#x2013;1000. doi: 10.1038/s41423-020-0514-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0514-8</ArticleId><ArticleId IdType="pmc">PMC7387808</ArticleId><ArticleId IdType="pubmed">32728199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pancer K., Milewska A., Owczarek K., Dabrowska A., Kowalski M., Labaj P.P., Branicki W., Sanak M., Pyrc K. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans. PLoS Pathog. 2020;16:e1008959. doi: 10.1371/journal.ppat.1008959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008959</ArticleId><ArticleId IdType="pmc">PMC7755277</ArticleId><ArticleId IdType="pubmed">33301543</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong S.Y., Matzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004;4:469&#x2013;478. doi: 10.1038/nri1372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1372</ArticleId><ArticleId IdType="pubmed">15173835</ArticleId></ArticleIdList></Reference><Reference><Citation>Broz P., Dixit V.M. Inflammasomes: Mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 2016;16:407&#x2013;420. doi: 10.1038/nri.2016.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.58</ArticleId><ArticleId IdType="pubmed">27291964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Nagasu H., Murakami T., Hoang H., Broderick L., Hoffman H.M., Horng T. Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc. Natl. Acad. Sci. USA. 2014;111:15514&#x2013;15519. doi: 10.1073/pnas.1414859111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1414859111</ArticleId><ArticleId IdType="pmc">PMC4217429</ArticleId><ArticleId IdType="pubmed">25313054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Karki R., Williams E.P., Yang D., Fitzpatrick E., Vogel P., Jonsson C.B., Kanneganti T.D. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 2021;22:829&#x2013;838. doi: 10.1038/s41590-021-00937-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00937-x</ArticleId><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R., Planz O. The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation. Int. J. Mol. Sci. 2023;24:6701. doi: 10.3390/ijms24076701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076701</ArticleId><ArticleId IdType="pmc">PMC10095430</ArticleId><ArticleId IdType="pubmed">37047674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell J.K., Askins J., Hall P.R., Davies D.R., Segal D.M. The dsRNA binding site of human Toll-like receptor 3. Proc. Natl. Acad. Sci. USA. 2006;103:8792&#x2013;8797. doi: 10.1073/pnas.0603245103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603245103</ArticleId><ArticleId IdType="pmc">PMC1482657</ArticleId><ArticleId IdType="pubmed">16720699</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Ohto U., Shibata T., Krayukhina E., Taoka M., Yamauchi Y., Tanji H., Isobe T., Uchiyama S., Miyake K., et al. Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA. Immunity. 2016;45:737&#x2013;748. doi: 10.1016/j.immuni.2016.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.09.011</ArticleId><ArticleId IdType="pubmed">27742543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R., Planz O. Could a Lower Toll-like Receptor (TLR) and NF-kappaB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron? Int. J. Mol. Sci. 2022;23:5966. doi: 10.3390/ijms23115966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23115966</ArticleId><ArticleId IdType="pmc">PMC9180620</ArticleId><ArticleId IdType="pubmed">35682644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad M.S., Shaik R.A., Ahmad R.K., Yusuf M., Khan M., Almutairi A.B., Alghuyaythat W.K.Z., Almutairi S.B. &#x201c;LONG COVID&#x201d;: An insight. Eur. Rev. Med. Pharmacol. Sci. 2021;25:5561&#x2013;5577.</Citation><ArticleIdList><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., Hallqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x2019;The long tail of COVID-19&#x2019;&#x2014;The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585:339&#x2013;341. doi: 10.1038/d41586-020-02598-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02598-6</ArticleId><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P., Arora U., Kumar A., Wig N. The "post-COVID" syndrome: How deep is the damage? J. Med. Virol. 2021;93:673&#x2013;674. doi: 10.1002/jmv.26465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26465</ArticleId><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V., Vitale C., Rispoli A., Izzo C., Virtuoso N., Ferruzzi G.J., Santopietro M., Melfi A., Rusciano M.R., Maglio A., et al. Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. J. Clin. Med. 2022;11:524. doi: 10.3390/jcm11030524.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Babicki M., Kapusta J., Kaluzinska-Kolat Z., Kolat D., Jankowski P., Mastalerz-Migas A. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study. Viruses. 2022;14:1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Budzynska N., Morys J. Anxiety and Depression Levels and Coping Strategies among Polish Healthcare Workers during the COVID-19 Pandemic. Int. J. Environ. Res. Public Health. 2023;20:3319. doi: 10.3390/ijerph20043319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043319</ArticleId><ArticleId IdType="pmc">PMC9959847</ArticleId><ArticleId IdType="pubmed">36834013</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Madlock-Brown C., Baratta J.M., Bhatia A., Davis H., Girvin A., Hill E., Kelly E., Kostka K., Loomba J., et al. Coding long COVID: Characterizing a new disease through an ICD-10 lens. BMC Med. 2023;21:58. doi: 10.1186/s12916-023-02737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lledo G.M., Sellares J., Brotons C., Sans M., Anton J.D., Blanco J., Bassat Q., Sarukhan A., Miro J.M., de Sanjose S., et al. Post-acute COVID-19 syndrome: A new tsunami requiring a universal case definition. Clin. Microbiol. Infect. 2022;28:315&#x2013;318. doi: 10.1016/j.cmi.2021.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.015</ArticleId><ArticleId IdType="pmc">PMC8610558</ArticleId><ArticleId IdType="pubmed">34826619</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of Antibody Immunity to SARS-CoV-2. bioRxiv. 2021 doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Nguyen V., Tsai J., Gao C., Tian Y., Zhang Y., Carver W., Kiaris H., Cui T., Tan W. The SARS-CoV-2 Spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice. bioRxiv. 2023 doi: 10.1101/2023.01.05.522853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.05.522853</ArticleId><ArticleId IdType="pmc">PMC10281040</ArticleId><ArticleId IdType="pubmed">37348737</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta C.S., Torices S., da Rosa B.G., Marcos A.C., Alvarez-Rosa L., Siqueira M., Moreno-Rodriguez T., Matos A.D.R., Caetano B.C., Martins J., et al. Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-kappaB Non-Canonical Pathway and Mitochondrial Remodeling. Viruses. 2023;15:745. doi: 10.3390/v15030745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030745</ArticleId><ArticleId IdType="pmc">PMC10056985</ArticleId><ArticleId IdType="pubmed">36992454</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G., Mustapic M., Kapogiannis D., Henrich T.J., Lu S., Goldberg S.A., Hoh R., Chen J.Y., Martinez E.O., et al. SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann. Neurol. 2022;91:772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K., Gasowski J., Michel J.P., Veronese N. Post-COVID-19 acute sarcopenia: Physiopathology and management. Aging Clin. Exp. Res. 2021;33:2887&#x2013;2898. doi: 10.1007/s40520-021-01942-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01942-8</ArticleId><ArticleId IdType="pmc">PMC8323089</ArticleId><ArticleId IdType="pubmed">34328636</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardacci R., Colavita F., Castilletti C., Lapa D., Matusali G., Meschi S., Del Nonno F., Colombo D., Capobianchi M.R., Zumla A., et al. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis. 2021;12:263. doi: 10.1038/s41419-021-03527-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03527-9</ArticleId><ArticleId IdType="pmc">PMC7952828</ArticleId><ArticleId IdType="pubmed">33712574</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese M., Lee J.Y., Cerikan B., Neufeldt C.J., Oorschot V.M.J., Kohrer S., Hennies J., Schieber N.L., Ronchi P., Mizzon G., et al. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies. Cell Host Microbe. 2020;28:853&#x2013;866.e5. doi: 10.1016/j.chom.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7670925</ArticleId><ArticleId IdType="pubmed">33245857</ArticleId></ArticleIdList></Reference><Reference><Citation>Faizan M.I., Chaudhuri R., Sagar S., Albogami S., Chaudhary N., Azmi I., Akhtar A., Ali S.M., Kumar R., Iqbal J., et al. NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles. Cells. 2022;11:2969. doi: 10.3390/cells11192969.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11192969</ArticleId><ArticleId IdType="pmc">PMC9561960</ArticleId><ArticleId IdType="pubmed">36230930</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K., Chen Y.C., Hassanzadeh S., Han K., Judy J.T., Seifuddin F., Tunc I., Sack M.N., Pirooznia M. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection. Front. Genet. 2021;12:599261. doi: 10.3389/fgene.2021.599261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.599261</ArticleId><ArticleId IdType="pmc">PMC8008150</ArticleId><ArticleId IdType="pubmed">33796130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mando C., Savasi V.M., Anelli G.M., Corti S., Serati A., Lisso F., Tasca C., Novielli C., Cetin I. Mitochondrial and Oxidative Unbalance in Placentas from Mothers with SARS-CoV-2 Infection. Antioxidants. 2021;10:1517. doi: 10.3390/antiox10101517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10101517</ArticleId><ArticleId IdType="pmc">PMC8533135</ArticleId><ArticleId IdType="pubmed">34679654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartsell E.M., Gillespie M.N., Langley R.J. Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Eur. Respir. J. 2022;59:2102417. doi: 10.1183/13993003.02417-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02417-2021</ArticleId><ArticleId IdType="pmc">PMC8542864</ArticleId><ArticleId IdType="pubmed">34675049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliss A., Kuzmin A.N., Prasad P.N., Mahajan S.D. Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV-2. ACS Chem. Neurosci. 2022;13:308&#x2013;312. doi: 10.1021/acschemneuro.1c00675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00675</ArticleId><ArticleId IdType="pmc">PMC8790819</ArticleId><ArticleId IdType="pubmed">35049274</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., She Z.G., Cheng X., Qin J.J., Zhang X.J., Cai J., Lei F., Wang H., Xie J., Wang W., et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020;31:1068&#x2013;1077 e1063. doi: 10.1016/j.cmet.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference><Reference><Citation>Garreta E., Prado P., Stanifer M.L., Monteil V., Marco A., Ullate-Agote A., Moya-Rull D., Vilas-Zornoza A., Tarantino C., Romero J.P., et al. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metab. 2022;34:857&#x2013;873 e859. doi: 10.1016/j.cmet.2022.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9097013</ArticleId><ArticleId IdType="pubmed">35561674</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L., Kokkinidis D.G., Li W., Karamanis D., Ognibene J., Arora S., Southern W.N., Mantzoros C.S. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType="pmc">PMC7228874</ArticleId><ArticleId IdType="pubmed">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Holder K., Reddy P.H. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia. Neuroscientist. 2021;27:331&#x2013;339. doi: 10.1177/1073858420960443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420960443</ArticleId><ArticleId IdType="pubmed">32981462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrogiannaki A.N., Migdalis I.N. Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: Newer data. Int. J. Endocrinol. 2013;2013:450639. doi: 10.1155/2013/450639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/450639</ArticleId><ArticleId IdType="pmc">PMC3638654</ArticleId><ArticleId IdType="pubmed">23653642</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa F.F., Rosario W.R., Ribeiro Farias A.C., de Souza R.G., Duarte Gondim R.S., Barroso W.A. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes Metab. Syndr. 2020;14:809&#x2013;814. doi: 10.1016/j.dsx.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7286828</ArticleId><ArticleId IdType="pubmed">32540733</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno Fernandez-Ayala D.J., Navas P., Lopez-Lluch G. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp. Gerontol. 2020;142:111147. doi: 10.1016/j.exger.2020.111147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.111147</ArticleId><ArticleId IdType="pmc">PMC7648491</ArticleId><ArticleId IdType="pubmed">33171276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X., Ismail N.I., Rahman A., Xu D., Chan R.W.Y., Ong S.G., Ong S.B. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link? Antioxid. Redox Signal. 2023;38:599&#x2013;618. doi: 10.1089/ars.2022.0126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2022.0126</ArticleId><ArticleId IdType="pmc">PMC10025846</ArticleId><ArticleId IdType="pubmed">36053670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Cao R., Zhong W. Host Calcium Channels and Pumps in Viral Infections. Cells. 2019;9:94. doi: 10.3390/cells9010094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010094</ArticleId><ArticleId IdType="pmc">PMC7016755</ArticleId><ArticleId IdType="pubmed">31905994</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z., Madara J.J., Herbert A., Prugar L.I., Ruthel G., Lu J., Liu Y., Liu W., Liu X., Wrobel J.E., et al. Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic Intervention. PLoS Pathog. 2015;11:e1005220. doi: 10.1371/journal.ppat.1005220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005220</ArticleId><ArticleId IdType="pmc">PMC4634230</ArticleId><ArticleId IdType="pubmed">26513362</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y., Sun Y., Yang Z., Ding C. Calcium Ions Signaling: Targets for Attack and Utilization by Viruses. Front. Microbiol. 2022;13:889374. doi: 10.3389/fmicb.2022.889374.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.889374</ArticleId><ArticleId IdType="pmc">PMC9289559</ArticleId><ArticleId IdType="pubmed">35859744</ArticleId></ArticleIdList></Reference><Reference><Citation>Saurav S., Tanwar J., Ahuja K., Motiani R.K. Dysregulation of host cell calcium signaling during viral infections: Emerging paradigm with high clinical relevance. Mol. Asp. Med. 2021;81:101004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299155</ArticleId><ArticleId IdType="pubmed">34304899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai A.L., Freed J.H. SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca(2) J. Mol. Biol. 2021;433:166946. doi: 10.1016/j.jmb.2021.166946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.166946</ArticleId><ArticleId IdType="pmc">PMC7969826</ArticleId><ArticleId IdType="pubmed">33744314</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus M.R., Tang T., Lai A.L., Flegel A., Bidon M., Freed J.H., Daniel S., Whittaker G.R. Ca(2+) Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity. J. Virol. 2020;94:e00426-20. doi: 10.1128/JVI.00426-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00426-20</ArticleId><ArticleId IdType="pmc">PMC7307142</ArticleId><ArticleId IdType="pubmed">32295925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern D.M., Sorum B., Mali S.S., Hoel C.M., Sridharan S., Remis J.P., Toso D.B., Kotecha A., Bautista D.M., Brohawn S.G. Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs. Nat. Struct. Mol. Biol. 2021;28:573&#x2013;582. doi: 10.1038/s41594-021-00619-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-021-00619-0</ArticleId><ArticleId IdType="pmc">PMC8772433</ArticleId><ArticleId IdType="pubmed">34158638</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J.P., Almasy K.M., McDonald E.F., Plate L. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies. ACS Infect. Dis. 2020;6:3174&#x2013;3189. doi: 10.1021/acsinfecdis.0c00500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00500</ArticleId><ArticleId IdType="pmc">PMC7724760</ArticleId><ArticleId IdType="pubmed">33263384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Shu T., Wu D., Mu J., Wang C., Huang M., Han Y., Zhang X.Y., Zhou W., Qiu Y., et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell. Mol. Immunol. 2020;17:881&#x2013;883. doi: 10.1038/s41423-020-0485-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0485-9</ArticleId><ArticleId IdType="pmc">PMC7301057</ArticleId><ArticleId IdType="pubmed">32555321</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D., Klann K., Koch B., Widera M., Krause D., Ciesek S., Cinatl J., Munch C. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583:469&#x2013;472. doi: 10.1038/s41586-020-2332-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2332-7</ArticleId><ArticleId IdType="pubmed">32408336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn A.V.W., Guy G.W., Brysch W., Bell J.D. Understanding Long COVID.; Mitochondrial Health and Adaptation-Old Pathways, New Problems. Biomedicines. 2022;10:3113. doi: 10.3390/biomedicines10123113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10123113</ArticleId><ArticleId IdType="pmc">PMC9775339</ArticleId><ArticleId IdType="pubmed">36551869</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu C., Zhang S., Wang W., Li M., Wang Y., van der Heijde-Mulder M., Shokrollahi E., Hakim M.S., Raat N.J.H., Peppelenbosch M.P., et al. Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target. FASEB J. 2019;33:1008&#x2013;1019. doi: 10.1096/fj.201800620R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201800620R</ArticleId><ArticleId IdType="pmc">PMC6355081</ArticleId><ArticleId IdType="pubmed">30070932</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D., Agusti A., Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Criner G.J., Frith P., Halpin D.M.G., Han M., et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD science committee report 2019. Eur. Respir. J. 2019;53:1900164. doi: 10.1183/13993003.00164-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00164-2019</ArticleId><ArticleId IdType="pubmed">30846476</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin C.S., Meng S., Garbis S.D., Moradian A., Taylor R.W., Sweredoski M.J., Lomenick B., Chan D.C. LONP1 and mtHSP70 cooperate to promote mitochondrial protein folding. Nat. Commun. 2021;12:265. doi: 10.1038/s41467-020-20597-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20597-z</ArticleId><ArticleId IdType="pmc">PMC7801493</ArticleId><ArticleId IdType="pubmed">33431889</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo A.C., Davanzo G.G., Monteiro L.B., de Souza G.F., Muraro S.P., Virgilio-da-Silva J.V., Prodonoff J.S., Carregari V.C., de Biagi Junior C.A.O., Crunfli F., et al. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis. Cell Metab. 2020;32:498&#x2013;499. doi: 10.1016/j.cmet.2020.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.015</ArticleId><ArticleId IdType="pmc">PMC7462530</ArticleId><ArticleId IdType="pubmed">32877692</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria-Castro E., Soto M.E., Guarner-Lans V., Rojas G., Perezpena-Diazconti M., Criales-Vera S.A., Manzano Pech L., Perez-Torres I. The kidnapping of mitochondrial function associated with the SARS-CoV-2 infection. Histol. Histopathol. 2021;36:947&#x2013;965.</Citation><ArticleIdList><ArticleId IdType="pubmed">34132382</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkov A.A., Fiskum G. Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state. J. Neurochem. 2003;86:1101&#x2013;1107. doi: 10.1046/j.1471-4159.2003.01908.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01908.x</ArticleId><ArticleId IdType="pubmed">12911618</ArticleId></ArticleIdList></Reference><Reference><Citation>Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 1998;281:1309&#x2013;1312. doi: 10.1126/science.281.5381.1309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5381.1309</ArticleId><ArticleId IdType="pubmed">9721092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wang L., Yan S., Yang F., Xiang L., Zhu J., Shen B., Gong Z. Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. Int. J. Infect. Dis. 2020;94:128&#x2013;132. doi: 10.1016/j.ijid.2020.03.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.053</ArticleId><ArticleId IdType="pmc">PMC7128884</ArticleId><ArticleId IdType="pubmed">32251805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Zhang J., Schiavon C.R., He M., Chen L., Shen H., Zhang Y., Yin Q., Cho Y., Andrade L., et al. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2. Circ. Res. 2021;128:1323&#x2013;1326. doi: 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C., Liu Z., Zhu Y., Lu J., Ge C., Zhang C., Li N., Jin N., Li Y., Tian M., et al. SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment. Front. Microbiol. 2021;12:780768. doi: 10.3389/fmicb.2021.780768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.780768</ArticleId><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade Silva M., da Silva A., do Amaral M.A., Fragas M.G., Camara N.O.S. Metabolic Alterations in SARS-CoV-2 Infection and Its Implication in Kidney Dysfunction. Front. Physiol. 2021;12:624698. doi: 10.3389/fphys.2021.624698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.624698</ArticleId><ArticleId IdType="pmc">PMC7947848</ArticleId><ArticleId IdType="pubmed">33716771</ArticleId></ArticleIdList></Reference><Reference><Citation>Moolamalla S.T.R., Balasubramanian R., Chauhan R., Priyakumar U.D., Vinod P.K. Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach. Microb. Pathog. 2021;158:105114. doi: 10.1016/j.micpath.2021.105114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.105114</ArticleId><ArticleId IdType="pmc">PMC8321700</ArticleId><ArticleId IdType="pubmed">34333072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Wang G., Xu Z.G., Tu H., Hu F., Dai J., Chang Y., Chen Y., Lu Y., Zeng H., et al. Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS. Cell. 2019;178:176&#x2013;189.e15. doi: 10.1016/j.cell.2019.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6625351</ArticleId><ArticleId IdType="pubmed">31155231</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomello M., Pyakurel A., Glytsou C., Scorrano L. The cell biology of mitochondrial membrane dynamics. Nat. Rev. Mol. Cell Biol. 2020;21:204&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">32071438</ArticleId></ArticleIdList></Reference><Reference><Citation>Terman A., Kurz T., Navratil M., Arriaga E.A., Brunk U.T. Mitochondrial turnover and aging of long-lived postmitotic cells: The mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 2010;12:503&#x2013;535. doi: 10.1089/ars.2009.2598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2598</ArticleId><ArticleId IdType="pmc">PMC2861545</ArticleId><ArticleId IdType="pubmed">19650712</ArticleId></ArticleIdList></Reference><Reference><Citation>De R., Sarkar S., Mazumder S., Debsharma S., Siddiqui A.A., Saha S.J., Banerjee C., Nag S., Saha D., Pramanik S., et al. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-kappaB signaling. J. Biol. Chem. 2018;293:19740&#x2013;19760. doi: 10.1074/jbc.RA118.003935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003935</ArticleId><ArticleId IdType="pmc">PMC6314129</ArticleId><ArticleId IdType="pubmed">30366984</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., Daugaard J.R., Lloberas J., Camps M., Zierath J.R., et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 2003;278:17190&#x2013;17197. doi: 10.1074/jbc.M212754200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M212754200</ArticleId><ArticleId IdType="pubmed">12598526</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.E., Tippetts T.S., Brassfield E.S., Tucker B.J., Ockey A., Swensen A.C., Anthonymuthu T.S., Washburn T.D., Kane D.A., Prince J.T., et al. Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle. Biochem. J. 2013;456:427&#x2013;439. doi: 10.1042/BJ20130807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20130807</ArticleId><ArticleId IdType="pubmed">24073738</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M., Prudent J., Basu K., Goyon V., Katsumura S., Hulea L., Pearl D., Siddiqui N., Strack S., McGuirk S., et al. mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1. Mol. Cell. 2017;67:922&#x2013;935.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28918902</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M., Gravel S.P., Hulea L., Larsson O., Pollak M., St-Pierre J., Topisirovic I. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 2015;14:473&#x2013;480. doi: 10.4161/15384101.2014.991572.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/15384101.2014.991572</ArticleId><ArticleId IdType="pmc">PMC4615141</ArticleId><ArticleId IdType="pubmed">25590164</ArticleId></ArticleIdList></Reference><Reference><Citation>Zemirli N., Pourcelot M., Ambroise G., Hatchi E., Vazquez A., Arnoult D. Mitochondrial hyperfusion promotes NF-kappaB activation via the mitochondrial E3 ligase MULAN. FEBS J. 2014;281:3095&#x2013;3112. doi: 10.1111/febs.12846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12846</ArticleId><ArticleId IdType="pubmed">24841215</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012;19:107&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3252826</ArticleId><ArticleId IdType="pubmed">21760595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007;87:99&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">17237344</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeddu E., Maniga B., Zaffanello M., Fanos V., Marcialis A. The SARS-CoV2 and mitochondria: The impact on cell fate. Acta Biomed. 2022;93:e2022199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9171887</ArticleId><ArticleId IdType="pubmed">35546040</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao G., Xing J., Xiao X., Liou A.K., Gao Y., Yin X.M., Clark R.S., Graham S.H., Chen J. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J. Neurosci. 2007;27:9278&#x2013;9293. doi: 10.1523/JNEUROSCI.2826-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2826-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673113</ArticleId><ArticleId IdType="pubmed">17728442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Kim N.S., Haince J.F., Kang H.C., David K.K., Andrabi S.A., Poirier G.G., Dawson V.L., Dawson T.M. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos) Sci. Signal. 2011;4:ra20. doi: 10.1126/scisignal.2000902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2000902</ArticleId><ArticleId IdType="pmc">PMC3086524</ArticleId><ArticleId IdType="pubmed">21467298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Kim N.S., Li X., Greer P.A., Koehler R.C., Dawson V.L., Dawson T.M. Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos) J. Neurochem. 2009;110:687&#x2013;696. doi: 10.1111/j.1471-4159.2009.06167.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06167.x</ArticleId><ArticleId IdType="pmc">PMC2819224</ArticleId><ArticleId IdType="pubmed">19457082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesavardhana S., Kanneganti T.D. Mechanisms governing inflammasome activation, assembly and pyroptosis induction. Int. Immunol. 2017;29:201&#x2013;210. doi: 10.1093/intimm/dxx018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxx018</ArticleId><ArticleId IdType="pmc">PMC5890894</ArticleId><ArticleId IdType="pubmed">28531279</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 2010;11:700&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">20823910</ArticleId></ArticleIdList></Reference><Reference><Citation>Redondo N., Zaldivar-Lopez S., Garrido J.J., Montoya M. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns. Front. Immunol. 2021;12:708264. doi: 10.3389/fimmu.2021.708264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.708264</ArticleId><ArticleId IdType="pmc">PMC8293742</ArticleId><ArticleId IdType="pubmed">34305949</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes-Aguayo J.J., Garza-Veloz I., Badillo-Almaraz J.I., Bernal-Silva S., Martinez-Vazquez M.C., Juarez-Alcala V., Vargas-Rodriguez J.R., Gaeta-Velasco M.L., Gonzalez-Fuentes C., Avila-Carrasco L., et al. Mitochondria and Mitochondrial DNA: Key Elements in the Pathogenesis and Exacerbation of the Inflammatory State Caused by COVID-19. Medicina. 2021;57:928. doi: 10.3390/medicina57090928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57090928</ArticleId><ArticleId IdType="pmc">PMC8471487</ArticleId><ArticleId IdType="pubmed">34577851</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirican E., Savrun S.T., Aydin I.E., Gulbay G., Karaman U. Analysis of mitochondrial DNA cytochrome-b (CYB) and ATPase-6 gene mutations in COVID-19 patients. J. Med. Virol. 2022;94:3138&#x2013;3146. doi: 10.1002/jmv.27704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27704</ArticleId><ArticleId IdType="pmc">PMC9088694</ArticleId><ArticleId IdType="pubmed">35258110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Wang X.H., Li X.H., Song L.Y., Yu S.L., Fang Z.C., Liu Y.Q., Yuan L.Y., Peng C.Y., Zhang S.Y., et al. Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China. Mil. Med. Res. 2021;8:57. doi: 10.1186/s40779-021-00351-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-021-00351-2</ArticleId><ArticleId IdType="pmc">PMC8558762</ArticleId><ArticleId IdType="pubmed">34724985</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley J.S., Tait S.W. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020;21:e49799. doi: 10.15252/embr.201949799.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949799</ArticleId><ArticleId IdType="pmc">PMC7132203</ArticleId><ArticleId IdType="pubmed">32202065</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi D., Cano M., Ma L., Zhou D., Zhu J.H., O&#x2019;Halloran J.A., Goss C., Rauseo A.M., Liu Z., Sahu S.K., et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021;6:143299. doi: 10.1172/jci.insight.143299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143299</ArticleId><ArticleId IdType="pmc">PMC7934921</ArticleId><ArticleId IdType="pubmed">33444289</ArticleId></ArticleIdList></Reference><Reference><Citation>Andargie T.E., Tsuji N., Seifuddin F., Jang M.K., Yuen P.S., Kong H., Tunc I., Singh K., Charya A., Wilkins K., et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight. 2021;6:147610. doi: 10.1172/jci.insight.147610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.147610</ArticleId><ArticleId IdType="pmc">PMC8119224</ArticleId><ArticleId IdType="pubmed">33651717</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J.H., Li Y.Y., Jin J. The essential functions of mitochondrial dynamics in immune cells. Cell. Mol. Immunol. 2020;17:712&#x2013;721. doi: 10.1038/s41423-020-0480-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0480-1</ArticleId><ArticleId IdType="pmc">PMC7331746</ArticleId><ArticleId IdType="pubmed">32523116</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson K.B., Zhou J. Role of reactive oxygen species and iron in host defense against infection. Front. Biosci. Landmark Ed. 2020;25:1600&#x2013;1616.</Citation><ArticleIdList><ArticleId IdType="pubmed">32114446</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.H., Koh K.Y., Lin K.M., Chou C.K. Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle Disorders. Int. J. Mol. Sci. 2022;23:12926. doi: 10.3390/ijms232112926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232112926</ArticleId><ArticleId IdType="pmc">PMC9653750</ArticleId><ArticleId IdType="pubmed">36361713</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B., Silverstein A., Flores M., Cao K., Kumagai H., Mehta H.H., Yen K., Kim S.J., Cohen P. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples. Sci. Rep. 2021;11:3. doi: 10.1038/s41598-020-79552-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79552-z</ArticleId><ArticleId IdType="pmc">PMC7794290</ArticleId><ArticleId IdType="pubmed">33420163</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Zhang D., Hu D., Zhou X., Zhou Y. The role of mitochondria in NLRP3 inflammasome activation. Mol. Immunol. 2018;103:115&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">30248487</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher J., Cappellano G., Omori A., Koshiba T., Millet G.P. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity. iScience. 2020;23:101631. doi: 10.1016/j.isci.2020.101631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101631</ArticleId><ArticleId IdType="pmc">PMC7524535</ArticleId><ArticleId IdType="pubmed">33015593</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Hara H., Nunez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem. Sci. 2016;41:1012&#x2013;1021. doi: 10.1016/j.tibs.2016.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2016.09.002</ArticleId><ArticleId IdType="pmc">PMC5123939</ArticleId><ArticleId IdType="pubmed">27669650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221&#x2013;225. doi: 10.1038/nature09663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09663</ArticleId><ArticleId IdType="pubmed">21124315</ArticleId></ArticleIdList></Reference><Reference><Citation>Volt H., Garcia J.A., Doerrier C., Diaz-Casado M.E., Guerra-Librero A., Lopez L.C., Escames G., Tresguerres J.A., Acuna-Castroviejo D. Same molecule but different expression: Aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin. J. Pineal Res. 2016;60:193&#x2013;205. doi: 10.1111/jpi.12303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12303</ArticleId><ArticleId IdType="pubmed">26681113</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Zhang M., Wang Y., Zheng F., Huang Y., Huang K., Yu Q., Cai C., Chen D., Tian Y., et al. Clinical characteristics of older and younger patients infected with SARS-CoV-2. Aging. 2020;12:11296&#x2013;11305. doi: 10.18632/aging.103535.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103535</ArticleId><ArticleId IdType="pmc">PMC7343458</ArticleId><ArticleId IdType="pubmed">32575073</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J., Jia Y., et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat. Commun. 2021;12:4664. doi: 10.1038/s41467-021-25015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25015-6</ArticleId><ArticleId IdType="pmc">PMC8329225</ArticleId><ArticleId IdType="pubmed">34341353</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C.S., Nabar N.R., Huang N.N., Kehrl J.H. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5:101. doi: 10.1038/s41420-019-0181-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-019-0181-7</ArticleId><ArticleId IdType="pmc">PMC6549181</ArticleId><ArticleId IdType="pubmed">31231549</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Torres J.L., DeDiego M.L., Verdia-Baguena C., Jimenez-Guardeno J.M., Regla-Nava J.A., Fernandez-Delgado R., Castano-Rodriguez C., Alcaraz A., Torres J., Aguilella V.M., et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014;10:e1004077. doi: 10.1371/journal.ppat.1004077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004077</ArticleId><ArticleId IdType="pmc">PMC4006877</ArticleId><ArticleId IdType="pubmed">24788150</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung S.Y., Yuen K.S., Ye Z.W., Chan C.P., Jin D.Y. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: Lessons from other pathogenic viruses. Emerg. Microbes Infect. 2020;9:558&#x2013;570. doi: 10.1080/22221751.2020.1736644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1736644</ArticleId><ArticleId IdType="pmc">PMC7103735</ArticleId><ArticleId IdType="pubmed">32172672</ArticleId></ArticleIdList></Reference><Reference><Citation>Astuti I., Ysrafil Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. 2020;14:407&#x2013;412. doi: 10.1016/j.dsx.2020.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.020</ArticleId><ArticleId IdType="pmc">PMC7165108</ArticleId><ArticleId IdType="pubmed">32335367</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz E.A., Amarilla A.A., Modhiran N., Parker S., Li X.X., Wijesundara D.K., Aguado J., Zamora A.P., McMillan C.L.D., Liang B., et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol. Psychiatry. 2022 doi: 10.1038/s41380-022-01831-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01831-0</ArticleId><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C.M., Wang L., Yoo D. Activation of NF-kappaB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. Sci. Rep. 2021;11:13464. doi: 10.1038/s41598-021-92941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92941-2</ArticleId><ArticleId IdType="pmc">PMC8242070</ArticleId><ArticleId IdType="pubmed">34188167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen I.Y., Moriyama M., Chang M.F., Ichinohe T. Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome. Front. Microbiol. 2019;10:50. doi: 10.3389/fmicb.2019.00050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00050</ArticleId><ArticleId IdType="pmc">PMC6361828</ArticleId><ArticleId IdType="pubmed">30761102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasuga Y., Zhu B., Jang K.J., Yoo J.S. Innate immune sensing of coronavirus and viral evasion strategies. Exp. Mol. Med. 2021;53:723&#x2013;736. doi: 10.1038/s12276-021-00602-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00602-1</ArticleId><ArticleId IdType="pmc">PMC8099713</ArticleId><ArticleId IdType="pubmed">33953325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebermeyer T., Cognasse F., Berthelot P., Mismetti P., Garraud O., Hamzeh-Cognasse H. Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword. Int. J. Mol. Sci. 2021;22:7894. doi: 10.3390/ijms22157894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157894</ArticleId><ArticleId IdType="pmc">PMC8347377</ArticleId><ArticleId IdType="pubmed">34360659</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa T.J., Potje S.R., Fraga-Silva T.F.C., da Silva-Neto J.A., Barros P.R., Rodrigues D., Machado M.R., Martins R.B., Santos-Eichler R.A., Benatti M.N., et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vascul. Pharmacol. 2022;142:106946. doi: 10.1016/j.vph.2021.106946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2021.106946</ArticleId><ArticleId IdType="pmc">PMC8612754</ArticleId><ArticleId IdType="pubmed">34838735</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Chen M., Cao H., Zhu Y., Zheng J., Zhou H. Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. Microbes Infect. 2013;15:88&#x2013;95. doi: 10.1016/j.micinf.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2012.10.008</ArticleId><ArticleId IdType="pmc">PMC7110875</ArticleId><ArticleId IdType="pubmed">23123977</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi V., Nguyen H.O., Sozio F., Schioppa T., Gaudenzi C., Laffranchi M., Scapini P., Passari M., Barbazza I., Tiberio L., et al. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. JCI Insight. 2021;6:150542. doi: 10.1172/jci.insight.150542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.150542</ArticleId><ArticleId IdType="pmc">PMC8492321</ArticleId><ArticleId IdType="pubmed">34375313</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti D., Gentili V., Rizzo S., Schiuma G., Beltrami S., Strazzabosco G., Fernandez M., Caccuri F., Caruso A., Rizzo R. TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganisms. 2021;9:1820. doi: 10.3390/microorganisms9091820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9091820</ArticleId><ArticleId IdType="pmc">PMC8465566</ArticleId><ArticleId IdType="pubmed">34576716</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervantes-Barragan L., Zust R., Weber F., Spiegel M., Lang K.S., Akira S., Thiel V., Ludewig B. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood. 2007;109:1131&#x2013;1137. doi: 10.1182/blood-2006-05-023770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-05-023770</ArticleId><ArticleId IdType="pmc">PMC8254533</ArticleId><ArticleId IdType="pubmed">16985170</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104&#x2013;107. doi: 10.1038/nature08780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08780</ArticleId><ArticleId IdType="pmc">PMC2843437</ArticleId><ArticleId IdType="pubmed">20203610</ArticleId></ArticleIdList></Reference><Reference><Citation>Digard P., Lee H.M., Sharp C., Grey F., Gaunt E. Intra-genome variability in the dinucleotide composition of SARS-CoV-2. Virus Evol. 2020;6:veaa057. doi: 10.1093/ve/veaa057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veaa057</ArticleId><ArticleId IdType="pmc">PMC7454914</ArticleId><ArticleId IdType="pubmed">33029383</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.A. STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation? Front. Immunol. 2020;11:611347. doi: 10.3389/fimmu.2020.611347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.611347</ArticleId><ArticleId IdType="pmc">PMC7858662</ArticleId><ArticleId IdType="pubmed">33552072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B., Zhang L., Lei C., Li Y., Mao A.P., Yang Y., Wang Y.Y., Zhang X.L., Shu H.B. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity. 2009;30:397&#x2013;407. doi: 10.1016/j.immuni.2009.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.01.008</ArticleId><ArticleId IdType="pubmed">19285439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X., Du M., Xie J., Luo T., Zhou Y., Zhang K., Li J., Chen D., Xu P., Jia M., et al. Mutations in TOMM70 lead to multi-OXPHOS deficiencies and cause severe anemia, lactic acidosis, and developmental delay. J. Hum. Genet. 2020;65:231&#x2013;240. doi: 10.1038/s10038-019-0714-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-019-0714-1</ArticleId><ArticleId IdType="pubmed">31907385</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.Y., Wei B., Shi H.X., Shan Y.F., Wang C. Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res. 2010;20:994&#x2013;1011. doi: 10.1038/cr.2010.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.103</ArticleId><ArticleId IdType="pubmed">20628368</ArticleId></ArticleIdList></Reference><Reference><Citation>Elesela S., Lukacs N.W. Role of Mitochondria in Viral Infections. Life. 2021;11:232. doi: 10.3390/life11030232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11030232</ArticleId><ArticleId IdType="pmc">PMC7998235</ArticleId><ArticleId IdType="pubmed">33799853</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y.Z., Wang S.Y., Zheng Z.Q., Yi H., Li W.W., Xu Z.S., Wang Y.Y. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Cell. Mol. Immunol. 2021;18:613&#x2013;620. doi: 10.1038/s41423-020-00571-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00571-x</ArticleId><ArticleId IdType="pmc">PMC7588591</ArticleId><ArticleId IdType="pubmed">33110251</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Zhuang M.W., Deng J., Zheng Y., Zhang J., Nan M.L., Zhang X.J., Gao C., Wang P.H. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J. Med. Virol. 2021;93:5376&#x2013;5389. doi: 10.1002/jmv.27050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen C.K., Lam J.Y., Wong W.M., Mak L.F., Wang X., Chu H., Cai J.P., Jin D.Y., To K.K., Chan J.F., et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg. Microbes Infect. 2020;9:1418&#x2013;1428. doi: 10.1080/22221751.2020.1780953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1780953</ArticleId><ArticleId IdType="pmc">PMC7473193</ArticleId><ArticleId IdType="pubmed">32529952</ArticleId></ArticleIdList></Reference><Reference><Citation>Minakshi R., Padhan K., Rani M., Khan N., Ahmad F., Jameel S. The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS ONE. 2009;4:e8342. doi: 10.1371/journal.pone.0008342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008342</ArticleId><ArticleId IdType="pmc">PMC2791231</ArticleId><ArticleId IdType="pubmed">20020050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokic G., Hillen H.S., Tegunov D., Dienemann C., Seitz F., Schmitzova J., Farnung L., Siewert A., Hobartner C., Cramer P. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat. Commun. 2021;12:279. doi: 10.1038/s41467-020-20542-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20542-0</ArticleId><ArticleId IdType="pmc">PMC7804290</ArticleId><ArticleId IdType="pubmed">33436624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevalainen O.P.O., Horstia S., Laakkonen S., Rutanen J., Mustonen J.M.J., Kalliala I.E.J., Ansakorpi H., Kreivi H.R., Kuutti P., Paajanen J., et al. Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial. Nat. Commun. 2022;13:6152. doi: 10.1038/s41467-022-33825-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33825-5</ArticleId><ArticleId IdType="pmc">PMC9579198</ArticleId><ArticleId IdType="pubmed">36257950</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L., Meli G., Poletti F., Rostagno R., Moglia R., Cantone M., Esposito M., Scianguetta C., Domenicale B., Di Pasquale F., et al. Risk factors and incidence of long-COVID syndrome in hospitalized patients: Does remdesivir have a protective effect? QJM Int. J. Med. 2022;114:865&#x2013;871. doi: 10.1093/qjmed/hcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab297</ArticleId><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiler J., Michaelis M., Naczk P., Leutz A., Langer K., Doerr H.W., Cinatl J., Jr. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem. Pharmacol. 2010;79:413&#x2013;420. doi: 10.1016/j.bcp.2009.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2009.08.025</ArticleId><ArticleId IdType="pubmed">19732754</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Chen Y., Seth S., Furukawa S., Compans R.W., Jones D.P. Inhibition of influenza infection by glutathione. Free Radic. Biol. Med. 2003;34:928&#x2013;936. doi: 10.1016/S0891-5849(03)00023-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(03)00023-6</ArticleId><ArticleId IdType="pubmed">12654482</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., Shi Z., Huang H., Zhu H., Zhou P., Zhu H., Ju D. Ability of recombinant human catalase to suppress inflammation of the murine lung induced by influenza A. Inflammation. 2014;37:809&#x2013;817. doi: 10.1007/s10753-013-9800-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-013-9800-2</ArticleId><ArticleId IdType="pmc">PMC7087580</ArticleId><ArticleId IdType="pubmed">24385240</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto M.E., Guarner-Lans V., Soria-Castro E., Manzano Pech L., Perez-Torres I. Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application. Medicina. 2020;56:386. doi: 10.3390/medicina56080386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina56080386</ArticleId><ArticleId IdType="pmc">PMC7466376</ArticleId><ArticleId IdType="pubmed">32752010</ArticleId></ArticleIdList></Reference><Reference><Citation>Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998;18:159&#x2013;163. doi: 10.1038/ng0298-159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0298-159</ArticleId><ArticleId IdType="pubmed">9462746</ArticleId></ArticleIdList></Reference><Reference><Citation>Melov S., Doctrow S.R., Schneider J.A., Haberson J., Patel M., Coskun P.E., Huffman K., Wallace D.C., Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci. 2001;21:8348&#x2013;8353. doi: 10.1523/JNEUROSCI.21-21-08348.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-21-08348.2001</ArticleId><ArticleId IdType="pmc">PMC6762800</ArticleId><ArticleId IdType="pubmed">11606622</ArticleId></ArticleIdList></Reference><Reference><Citation>De R., Mazumder S., Sarkar S., Debsharma S., Siddiqui A.A., Saha S.J., Banerjee C., Nag S., Saha D., Bandyopadhyay U. Acute mental stress induces mitochondrial bioenergetic crisis and hyper-fission along with aberrant mitophagy in the gut mucosa in rodent model of stress-related mucosal disease. Free Radic. Biol. Med. 2017;113:424&#x2013;438. doi: 10.1016/j.freeradbiomed.2017.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.10.009</ArticleId><ArticleId IdType="pubmed">28993273</ArticleId></ArticleIdList></Reference><Reference><Citation>Petcherski A., Sharma M., Satta S., Daskou M., Vasilopoulos H., Hugo C., Ritou E., Dillon B.J., Fung E., Garcia G., et al. Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models. bioRxiv. 2022 doi: 10.1101/2022.02.22.481100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.22.481100</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittmar M., Lee J.S., Whig K., Segrist E., Li M., Kamalia B., Castellana L., Ayyanathan K., Cardenas-Diaz F.L., Morrisey E.E., et al. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Rep. 2021;35:108959. doi: 10.1016/j.celrep.2021.108959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108959</ArticleId><ArticleId IdType="pmc">PMC7985926</ArticleId><ArticleId IdType="pubmed">33811811</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth E., Maleth J., Zavogyan N., Fanczal J., Grassalkovich A., Erdos R., Pallagi P., Horvath G., Tretter L., Balint E.R., et al. Novel mitochondrial transition pore inhibitor N-methyl-4-isoleucine cyclosporin is a new therapeutic option in acute pancreatitis. J. Physiol. 2019;597:5879&#x2013;5898. doi: 10.1113/JP278517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP278517</ArticleId><ArticleId IdType="pubmed">31631343</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakoory B., Carcillo J.A., Chatham W.W., Amdur R.L., Zhao H., Dinarello C.A., Cron R.Q., Opal S.M. Interleukin-1 Receptor Blockade Is Associated with Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit. Care Med. 2016;44:275&#x2013;281. doi: 10.1097/CCM.0000000000001402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001402</ArticleId><ArticleId IdType="pmc">PMC5378312</ArticleId><ArticleId IdType="pubmed">26584195</ArticleId></ArticleIdList></Reference><Reference><Citation>Norelli M., Camisa B., Barbiera G., Falcone L., Purevdorj A., Genua M., Sanvito F., Ponzoni M., Doglioni C., Cristofori P., et al. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med. 2018;24:739&#x2013;748. doi: 10.1038/s41591-018-0036-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0036-4</ArticleId><ArticleId IdType="pubmed">29808007</ArticleId></ArticleIdList></Reference><Reference><Citation>Le R.Q., Li L., Yuan W., Shord S.S., Nie L., Habtemariam B.A., Przepiorka D., Farrell A.T., Pazdur R. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome. Oncologist. 2018;23:943&#x2013;947. doi: 10.1634/theoncologist.2018-0028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2018-0028</ArticleId><ArticleId IdType="pmc">PMC6156173</ArticleId><ArticleId IdType="pubmed">29622697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotch C., Barrett D., Teachey D.T. Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome. Expert Rev. Clin. Immunol. 2019;15:813&#x2013;822. doi: 10.1080/1744666X.2019.1629904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2019.1629904</ArticleId><ArticleId IdType="pmc">PMC7936577</ArticleId><ArticleId IdType="pubmed">31219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., Hlh Across Speciality Collaboration U.K. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Giavridis T., van der Stegen S.J.C., Eyquem J., Hamieh M., Piersigilli A., Sadelain M. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat. Med. 2018;24:731&#x2013;738. doi: 10.1038/s41591-018-0041-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0041-7</ArticleId><ArticleId IdType="pmc">PMC6410714</ArticleId><ArticleId IdType="pubmed">29808005</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijay R., Fehr A.R., Janowski A.M., Athmer J., Wheeler D.L., Grunewald M., Sompallae R., Kurup S.P., Meyerholz D.K., Sutterwala F.S., et al. Virus-induced inflammasome activation is suppressed by prostaglandin D(2)/DP1 signaling. Proc. Natl. Acad. Sci. USA. 2017;114:E5444&#x2013;E5453. doi: 10.1073/pnas.1704099114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704099114</ArticleId><ArticleId IdType="pmc">PMC5502630</ArticleId><ArticleId IdType="pubmed">28630327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli G., De Luca G., Campochiaro C., Della-Torre E., Ripa M., Canetti D., Oltolini C., Castiglioni B., Tassan Din C., Boffini N., et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: A retrospective cohort study. Lancet Rheumatol. 2020;2:e325&#x2013;e331. doi: 10.1016/S2665-9913(20)30127-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30127-2</ArticleId><ArticleId IdType="pmc">PMC7252085</ArticleId><ArticleId IdType="pubmed">32501454</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccoli C., Scrima R., Quarato G., D&#x2019;Aprile A., Ripoli M., Lecce L., Boffoli D., Moradpour D., Capitanio N. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology. 2007;46:58&#x2013;65. doi: 10.1002/hep.21679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.21679</ArticleId><ArticleId IdType="pubmed">17567832</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods J.J., Wilson J.J. Inhibitors of the mitochondrial calcium uniporter for the treatment of disease. Curr. Opin. Chem. Biol. 2020;55:9&#x2013;18. doi: 10.1016/j.cbpa.2019.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2019.11.006</ArticleId><ArticleId IdType="pubmed">31869674</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>